HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ka-Loh Li Selected Research
Ka-Loh Li Research Topics
Disease
10
Neoplasms (Cancer)
10/2021 - 10/2005
4
Acoustic Neuroma (Acoustic Neurinoma)
01/2021 - 01/2014
3
Breast Neoplasms (Breast Cancer)
12/2007 - 10/2005
2
Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018 - 02/2016
1
Inflammation (Inflammations)
01/2019
1
Glioblastoma (Glioblastoma Multiforme)
01/2018
1
Meningioma (Meningiomas)
01/2014
1
Necrosis
10/2005
Drug/Important Bio-Agent (IBA)
4
Biomarkers (Surrogate Marker)
IBA
05/2020 - 04/2007
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2016 - 10/2005
2
Phosphotransferases (Kinase)
IBA
12/2007 - 04/2007
2
Tyrosine Kinase Inhibitors
IBA
12/2007 - 10/2005
2
Tyrosine (L-Tyrosine)
FDA Link
12/2007 - 04/2007
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
04/2007 - 10/2005
2
Axitinib (AG 013736)
IBA
04/2007 - 10/2005
1
Eosine Yellowish-(YS) (Eosin)
IBA
10/2021
1
Hematoxylin (Haematoxylon)
IBA
10/2021
1
PK 11195 (PK11195)
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
01/2019
1
Fibrinogen (Factor I)
FDA Link
01/2019
1
Bevacizumab (Avastin)
FDA Link
01/2018
1
Ice
IBA
08/2012
1
Gadolinium
IBA
07/2008
1
ErbB Receptors (EGF Receptor)
IBA
12/2007
1
Growth Factor Receptors
IBA
12/2007
1
Biological Products
IBA
12/2007
1
Gefitinib (Iressa)
FDA Link
12/2007
Therapy/Procedure
5
Therapeutics
01/2021 - 10/2005
1
Microspheres (Microsphere)
01/2018
1
Neoadjuvant Therapy
07/2008